A case series of myocardial infarction in SARS‐CoV‐2‐infected patients: Same complication, different outcomes-Reference-Cited by-同舟云学术

A case series of myocardial infarction in SARS‐CoV‐2‐infected patients: Same complication, different outcomes

Published:2022-01 Issue:1 Volume:10 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Alizadehasl Azin¹,Eslami Samira²^ORCID,Vakili Kimia³^ORCID,Habibi Khorasani Shirin²^ORCID,Haghazali Mehrdad⁴,khalilipur Ehsan⁵

Affiliation:

1. Cardiology Head of Cardio‐Oncology Department and Research Center Rajaie Cardiovascular Medical & Research CenterIran University of Medical Science Tehran Iran

2. Echocardiologist Department of Adult Echocardiography Rajaie Cardiovascular Medical and Research Center Tehran Iran

3. Student Research Committee Faculty of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran

4. Gastroenterologist Rajaie Cardiovascular Medical and Research Center Iran University of Medical Sciences Tehran Iran

5. Interventional Cardiologist Cardiovascular Intervention Research Center Rajaie Cardiovascular Medical and Research Center Tehran Iran

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.5304

Reference37 articles.

1. Clinical Characteristics of Coronavirus Disease 2019 in China

2. ST-Elevation Myocardial Infarction in Patients With COVID-19

3. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis

4. Pathological evidence of pulmonary thrombotic phenomena in severe COVID‐19

5. Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolonged Use of Tirofiban Infusion Without Percutaneous Coronary Intervention To Achieve Optimal Results in a COVID-19 Positive Patient With Inferior ST Segment Elevated Myocardial Infarction (STEMI) Secondary to Thromboembolism: A Case Report;Cureus;2022-10-14

2. Azithromycin/hydroxychloroquine;Reactions Weekly;2022-03